Sunday October 26, 2014
Sep-29-2012 21:55TweetFollow @OregonNews
Part 2 - Partnership for a Drug Free America.org AKA Partnership at a Drug Free America.orgMarianne Skolek Salem-News.com
Where is their outrage at Clinical Trials of OxyContin on Children ages 6 to 16?
(MYRTLE BEACH SC) - Since there is confusion on the actual name of this organization, I will refer to them as "Partnership" in this article until they make the necessary corrections on the Internet to end any further misinformation on their part.
This was posted on Partnership's website dated July 2012
Maker of OxyContin Plans to Study the Painkiller in Children
By Join Together Staff | July 9, 2012 | Leave a comment | Filed in Prescription Drugs, Research & Youth
The maker of OxyContin has announced it will study the safety of the painkiller in children, according to The Wall Street Journal. Purdue Pharma LP hopes the study will allow the company to gain six extra months of patent protection for the drug, the newspaper states.
The company will study the effects of two daily doses of OxyContin on more than 150 children ages 6 to 16 who have moderate to severe pain. If the study passes review by the Food and Drug Administration (FDA), the company will win a six-month extension on its patent for the original formulation of the drug, which is due to expire in April 2013.
According to the company, less than 0.3 percent of the 5.6 million OxyContin prescriptions written for the 12 months ending in May were for patients under age 19.
The FDA is encouraging drug companies to conduct pediatric trials, by offering to extend drugs’ exclusive manufacturing rights by six months. The agency wants to improve clinical data on the effects of medications on children. “One of FDA’s top priorities is giving pediatricians and parents the same level of tested and researched information on drugs used to treat children that is required for drugs used to treat adults,” FDA spokeswoman Sandy Walsh told the newspaper.
Purdue Pharma is also arguing in court that a reformulated version of the drug may substantially decrease abuse of the opioid. The company spent $100 million to develop the new version of OxyContin. According to the company, the new formulation, introduced in 2010, is more difficult to abuse than the original pill. The patent on the new formulation extends to 2025. Several generic drug manufacturers are seeking to make their own versions of OxyContin.
My question to the Partnership advocating "education" and not "treatment" as relates to these dangerous and addictive painkillers is this. Where is the outrage? Clinical trials on a drug that has crippled this country and Canada in addiction and death in record numbers -- and now potentially being used on children? Partnership and the FDA should be furious that these trials will be conducted on children. Oh and if Partnership and the victims of OxyContin are buying what the FDA is selling that this has to do with patent extension of OxyContin, I have a bridge to sell them.
Last week I wrote about a man who lost his 20 year old son, in 2011 because of being over-prescribed painkillers. The young man committed suicide and died in his father's arms. Partnership invited the father to come to the New York Stock Exchange to ring the closing bell in honor of his dead son and the loss of life to the prescription drug epidemic. The spokeswoman for Partnership is the former child star of Little House on the Prairie, Melissa Gilbert and she is shown in the photo in this article. I am sure it is easy for the "Hollywood Starlet" to be picked out from this photo so it won't be necessary for me to identify her.
Melissa Gilbert should research her ties to Partnership and their financial ties to the maker of OxyContin, Purdue Pharma. She might also want to look into how many families in every state in the country have lost loved ones to addiction and death to OxyContin because Purdue Pharma lied about the dangers of the painkiller.
I sometimes overdo the words "shame on you" -- but I can't think of anything else to say to Melissa Gilbert. You are a spokeswoman for an organization funded by the most notoriously criminal pharmaceutical company in our history -- and an organization that doesn't demonstrate any concern for clinical trials on children of this devastating painkiller.
Just posting the information on the Partnership website does not cut it. Are we to sit back now and wait until the statistics of young children being given this dangerous drug die or become so addicted their families will be looking into drug rehab facilities for children? Implausible? No it's happening under our noses and Partnership condones it by their silence.
At the bottom of this article is yet another helpful resource from Partnership named "Time to Get Help". Interesting that they were able to initiate this "helpful tool" as a result of a "leadership grant" sponsored by Purdue Pharma by an "anonymous donor". I'm curious about the anonymity of the donor so I may have to refer this to the Sackler family, owners of Purdue Pharma and their profits made off OxyContin.
Partnership had been the subject of criticism when it was revealed by the Village Voice that their federal tax returns showed that they had received several million dollars worth of funding from major pharmaceutical, tobacco and alcohol corporations - including the pharmaceutical company, Purdue Pharma. In 1997 Partnership discontinued any direct fiscal association with tobacco and alcohol suppliers, although it still receives financial support from the billion dollar plus pharmaceutical industry.
Maybe Melissa Gilbert should renew her Screen Actor Guild card and get some honest work -- you know not the kind where money is taken from a pharmaceutical company responsible for hundreds of thousands deaths and addictions in this country. Kind of taints the Little House on the Prairie image of her.
"Time to Get Help" information from the Partnership at Drugfree.org AKA Partnership for Drugfree.org:
The Partnership at Drugfree.org Launches First-of-Its-Kind Resource To Help Parents in Crisis Understand and Navigate Adolescent Drug and Alcohol Treatment and calls it Time to Get Help.
Research shows parents seek one destination for intervention and treatment information; Time To Get Help provides streamlined, research-based tools to address these issues
Experts and parents, including new celebrity spokesperson Melissa Gilbert, tout need for help and peer-to-peer support
NEW YORK, Dec. 9, 2010 /PRNewswire-USNewswire/ -- Nine million of America's teens and young adults are struggling with drugs and alcohol(1), yet unlike most other adolescent health issues or diseases, parents have not found a concise path to resources and support for teen drug and alcohol addiction. In response, The Partnership at Drugfree.org has launched Time To Get Help (http://timetogethelp.
The Need: Trial and Error Dominate Struggle to Find a Solution
Of the nine million teens and young adults needing treatment, two million are between the ages of 12-17, and ninety percent of those are not getting the help they need.(2) Research from the 2009 Partnership Attitude Tracking Study, sponsored by MetLife Foundation, also shows that parents of teens in trouble are more likely to go to the Internet for help, yet they often struggle with confusing and convoluted intervention and treatment information. This results in frustration and misssteps in their ongoing search for the 'perfect' treatment options for their child.
"If you search the web for 'teen drug problem,' you find more than 300,000 results. If you do a search for 'drug treatment,' the number climbs to more than 31 million. With millions of pages of information, it's no wonder parents are uncertain of where and who to turn to when dealing with teen addiction," said Steve Pasierb, President and CEO of The Partnership at Drugfree.org. "Time To Get Help bridges the gap between the questions parents have when it comes to their child's drug and alcohol addiction and the answers and resources they desperately need for treatment. It was created with parents – and for parents – as one destination to find easy-to-use, non-judgmental and science-based information and support."
"Time To Get Help comes right at the time when you know your child has a problem and you don't know where to go. You don't know who to talk to," said Melissa Gilbert, spokesperson for The Partnership at Drugfree.org. "Dedicated to treatment, it gives you the precise knowledge and resources you need to help a child in crisis. And the site's online community provides parents a place to breathe, a place to feel safe and to know that they are not alone."
Addressing the need for clear, available information for parents, the new peer-to-peer resource offers two practical e-Books, both free of charge, that educate them on what they need to know about youth intervention and treatment. The downloadable e-Books and new site provide the most current information and cutting-edge advice from experts including the Treatment Research Institute (TRI), one of the field's leading research groups specializing in addiction and substance use issues. TRI's senior researchers and the organization's own Science Advisory Board helped to translate research into the most effective and practical tools for parents at Time To Get Help.
Housed under the "Get Treatment" and the "Learn" sections of The Partnership at Drugfree.org's newly relaunched website, the Intervention e-Book helps parents respond when they think or know their child is using alcohol or other drugs. The organization's Treatment e-Book provides advice and guidance when it appears their child may need treatment for a serious drug problem, including the right questions to ask a prospective treatment program and tips on how to pay for treatment.
"Too many treatment providers, as well as society at large, blame parents for the youth's addiction or ignore them in the recognition, treatment and recovery process," said Gayle A. Dakof, PhD, member of The Partnership at Drugfree.org Science Advisory Board and Research Associate Professor at the University of Miami Miller School of Medicine. "This is why Time To Get Help is so important. The site not only gives parents access to the highest quality information and treatment for their children, but also underscores the important fact that they are not part of the problem, but a critical part of the solution."
Along with its "Community" section where parents can share their stories, Time To Get Help also features "Helping Hand," where difficult questions can be asked and peer-to-peer and expert advice on intervention, treatment and recovery are offered. Under "Make a Plan," worksheets and guides help direct a parent's conversation with treatment program staff in deciding which one is the best fit for their child and checklists help them take care of their own emotional needs while going through these times.
Time To Get Help was guided by the input and real-world experiences of the organization's Parent Advisory Board, including mom Patricia Genereux. "I struggled to understand my daughter's behavior. I asked myself if it was common young adult behavior or something more. We didn't understand how best to get an intervention or if one was even appropriate." She continues, "I wish we had been able to click on Time To Get Help to help navigate through the maze of information. The tools, conversation examples and guidance on the site help families understand the disease itself, prevention measures, intervention, treatment and recovery. It's the best start any parent could hope for to learn, find support and take action."
Opening up about these difficult issues isn't always easy. In response, the site's online community allows parents to connect and ask questions – openly or anonymously. The forum helps them wherever they are on their path, from those who recently discovered their child is suffering from drug or alcohol addiction to those who need support with treatment and recovery.
"Receiving support from others who have been through what you are going through can be very powerful and helpful, and often one of the most effective ways to stay hopeful, inspired and sane," said Lorraine McNeill-Popper, a mom and a member of The Partnership at Drugfree.org Parent Advisory Board. "You will find out that you are not alone in this fight against addiction and learn from other parents."
LP - Thank you for the best Thanksgiving and Christmas presents you could ever give me -- visits with our kids. You are da best and will be crowned at The Palace. I treasure and love you always!
Salem-News.com Investigative Reporter Marianne Skolek, is an Activist for Victims of OxyContin and Purdue Pharma throughout the United States and Canada. In July 2007, she testified against Purdue Pharma in Federal Court in Virginia at the sentencing of their three CEO's - Michael Friedman, Howard Udell and Paul Goldenheim - who pleaded guilty to charges of marketing OxyContin as less likely to be addictive or abused to physicians and patients. She also testified against Purdue Pharma at a Judiciary Hearing of the U.S. Senate in July 2007. Marianne works with government agencies and private attorneys in having a voice for her daughter Jill, who died in 2002 after being prescribed OxyContin, as well as the voice for scores of victims of OxyContin. She has been involved in her work for the past 8-1/2 years and is currently working on a book that exposes Purdue Pharma for their continued criminal marketing of OxyContin.
Marianne is a nurse having graduated in 1991 as president of her graduating class. She also has a Paralegal certification. Marianne served on a Community Service Board for the Courier News, a Gannet newspaper in NJ writing articles predominantly regarding AIDS patients and their emotional issues. She was awarded a Community Service Award in 1993 by the Hunterdon County, NJ HIV/AIDS Task Force in recognition of and appreciation for the donated time, energy and love in facilitating a Support Group for persons with HIV/AIDS.
Articles for September 28, 2012 | Articles for September 29, 2012 | Articles for September 30, 2012
|Contact: firstname.lastname@example.org | Copyright © 2014 Salem-News.com | news tips & press releases: email@example.com.|